Edwards Lifesciences (EW) numbers were cut at Credit Suisse. Shares are now seen reaching $73. Estimates were also reduced, given higher expected TAVI costs, Credit Suisse said. Neutral rating.
The Hartford (HIG) estimates were raised at UBS. Reflects progress in property and casualty insurance, along with an improvement in run-off risk, UBS said.
Herbalife (HLF) estimates were increased at DA Davidson through 2014. Company is seeing higher sales across the board, DA Davidson said. Buy rating.
Mattress Firm (MFRM) price target and estimates were increased at UBS after a meeting with management. The company is poised to build share, and vendor dynamics will have a positive impact, UBS said. The new price target is $43.MicroStrategy (MSTR) price target and estimates were cut at UBS. The company missed first-quarter estimates by a wide margin and continues to underperform the BI market. The estimates were reduced, and the price target was cut to $100. Plum Creek (PCL) estimates were reduced at UBS. Heavier weighting of profitability improvement coming from land sales, UBS said. Petsmart (PETM) was added to the Best Idea List at Wedbush. $82 price target. Investor concerns are overdone, Wedbush said. Outperform rating. PartnerRe (PRE) estimates were raised at UBS. Primarily reflects the first-quarter earnings beat, even as competition intensifies, UBS said. Riverbed Technology (RVBD) price target and estimates were reduced at Citigroup. WOC growth continues to slow, and product growth may soon turn negative, Citigroup said. Price target is now $15. Riverbed Technology price target and estimates were reduced at Wells Fargo. There is U.S. Federal weakness, macro pressures and the potential for disruptions in the OPNET business, Wells Fargo said. Price target range is now $13 to $16. SBA Communications (SBAC) price target and estimates were increased at Citigroup. Higher AFFO per share estimates, Citigroup said. Price target is now $90. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts